Exclusive: J&J attracts Chinese interest for diabetes business in potential $3-4 billion deal - sources
January 17, 2018 at 06:09 AM EST
HONG KONG (Reuters) - Chinese bidders are circling a diabetes care business owned by the world's largest healthcare company Johnson & Johnson in a deal that could fetch up to $4 billion, five people with direct knowledge told Reuters.
